Hexagon Purus receives follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR
Hexagon Purus, through its wholly owned subsidiary Wystrach GmbH (“Wystrach”), has received a follow-on order for hydrogen distribution systems from PAK PCE BIOPALIWA I WODÓR (“PAC PCE”), a company owned by ZE PAK, Poland’s largest privately owned electricity producer. ZE PAK and GRUPA POLSAT PLUS are strategically investing in hydrogen activities across the industrial and mobility sectors with the aim to contribute to their joint strategy to accelerate the ongoing green shift in Poland, where hydrogen will play an integral part to decarbonize “hard to abate” sectors.
The follow-on order can be viewed in conjunction with the announcement in Hexagon Purus’ Q4 2021 presentation for hydrogen distribution systems and mobile hydrogen refueling stations. The value of the follow-on order is approximately EUR 3.5 million (approximately NOK 36 million).
Driving Energy Transformation
“The companies of Mr. Zygmunt Solorz want to become leading producers of clean energy in Poland”, says Maciej Stec, Vice President of the Management Board for Strategy, Polsat Plus Group and Member of the Supervisory Board of ZE PAK SA. “As a Group, we want to change the world, and the world is turning to green hydrogen. It will play an important role in the global energy transformation. Green hydrogen can be used in many sectors of the economy, which will accelerate the reduction of CO2 and other harmful substances. Green hydrogen is also the new zero-emission fuel of the future. There are already thousands of hydrogen cars and buses on the road today. We want to build the full value chain of green hydrogen: from production in the electrolysis process using clean energy and water, through storage and transport, building a network of hydrogen refueling stations, production of buses to its widespread use in Poland. We are pleased to have the support of Hexagon Purus in our efforts to strengthen the hydrogen footprint in Poland”.
“Hydrogen is gathering strong momentum as a key energy transition pillar towards zero emission, and it plays an important role within the “hard to abate” sectors to decarbonize our society”, says Matthias Kötter, Head of Wystrach Sales, Hexagon Purus. “We are proud to yet again be the chosen supplier to support PAK PCE investments into decarbonizing the industry and mobility sectors in Poland”.
About the market
The mobility sectors are accountable for approximately to 20% of annual carbon emissions globally, and hydrogen has a significant role to play in reducing these emissions, particularly in “hard to abate” sectors. Making green hydrogen available for use in mobility applications is critical to reduce carbon emissions.
Poland emits more than 400 million tons of carbon emission annually and approximately 70% of the total energy production is still sourced from coal. Making green hydrogen available is a key prerequisite for the Polish energy sector to transition into zero-emission energy and to secure cheaper energy.
On 2 November 2021, the Council of Ministers approved the Polish Hydrogen Strategy to the year 2030 with an outlook to the year 2040. The strategy sets out the main objectives and cover 40 actions for the development of a low carbon hydrogen economy in Poland with emphasis on the use of hydrogen in the energy, transport, and industry sectors. Within transport, key goals of 2030 include the capacity for 2 GW electrolyzers, the roll-out of 800-1,000 new FCEV buses and the installation of a minimum of 32 hydrogen refueling stations.
The delivery of the hydrogen distribution systems is scheduled from Q1 to Q2, 2023.
For more information:
Mathias Meidell, Investor Relations Director, Hexagon Purus
Telephone: +47 909 82 242 | email@example.com
About Polsat Plus Group
Polsat Plus Group is one of the largest Polish companies and a leading media and telecommunications group in the region. It provides 20 million services to its individual and business customers. Polsat Plus Group, whose founder and majority shareholder is Zygmunt Solorz, is expanding its multiplay strategy to include the production and sale of clean energy. As part of the Strategy 2023+, a new segment – Clean Energy – will be developed. Polsat Plus Group wants to provide Poles with cheap and clean energy and support Poland’s aim to transform its energy sector towards zero- and low-emission energy. The Clean Energy segment is also in line with the ESG (Environment, Society, Corporate Governance) concept of building the Group's value in a sustainable manner, which takes into account and addresses environmental, social as well as responsible and transparent business-related issues.
About PAK PCE BIOPALIWA I WODÓR AND ZE PAK
PAK PCE BIOPALIWA I WODÓR is ZE PAK subsidiary responsible for green hydrogen production and distribution. ZE PAK is the largest private electricity producer in Poland with over 60 years of experience in the electricity generation sector. ZE PAK is currently implementing an ambitious energy transformation plan: the transition from coal to zero-emission energy production and the construction of a nationwide, full value chain of renewable hydrogen. Lignite-fired power stations will be phased out, and production based on lignite will be phased out by the end of this decade. In 2021, the ZE PAK Group produced 4.36 TWh of electricity, and revenues amounted to PLN 2.2 billion. The Group currently employs nearly 3,500 people. The ZE PAK Group is controlled by Mr. Zygmunt Solorz, one of the largest and most well-known entrepreneurs in Poland, with activities in the media, telecommunications, and real estate sectors.
About Hexagon Purus
Hexagon Purus, a Hexagon Composites company, enables zero emission mobility for a cleaner energy future. Hexagon Purus is a world leading provider of Hydrogen Type 4 high-pressure cylinders, complete vehicle systems and battery packs for fuel cell electric and battery electric vehicles (FCEV and BEV) including hybrid mobility applications on light, medium and heavy-duty vehicles, transit buses, ground storage, distribution, marine, rail, and aerospace applications.
Learn more at www.hexagonpurus.com and follow @HexagonPurus on Twitter and LinkedIn.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Basilea reports progress on the implementation of its strategy to focus on anti-infectives27.6.2022 07:15:00 CEST | Press release
ERADICATE phase 3 study exploring ceftobiprole for the treatment of patients with Staphylococcus aureus bacteremia (SAB) expected to report results shortlySeparate transactions for TTK/PLK1 inhibitor (BAL0891) and preclinical oncology projects expected to be concluded in H2 2022 No expansion of ongoing lisavanbulin clinical studies; exploring partnering opportunitiesDerazantinib rights to be transferred back to Merck & Co. by the end of 2022No material expenses related to oncology activities beyond 2022 and sustainable profitability expected in 2023Strategy implementation on track Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, June 27, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today an update on the progress made in the implementation of its strategic focus on anti-infectives. David Veitch, Chief Executive Officer, stated: “We have made significant progress in the implementation of our new strategy. Wit
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens
Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release
24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release
With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au
Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo